ACM
STOK icon

Aquatic Capital Management’s Stoke Therapeutics STOK Stock Holding History

Aquatic Capital Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,099
Closed -$126K – 1657
2025
Q2 		$126K Sell
11,099
-12,544
-53% -$119K ﹤0.01% 1067
2025
Q1 		$157K Buy
+23,643
New +$220K ﹤0.01% 989
2024
Q2 		– Sell
-9,600
Closed -$130K – 1580
2024
Q1 		$130K Buy
+9,600
New +$58.2K ﹤0.01% 860
2023
Q1 		– Sell
-100
Closed -$1K – 1733
2022
Q4 		$1K Sell
100
-7,600
-99% -$79K ﹤0.01% 1292
2022
Q3 		$99K Buy
7,700
+5,700
+285% +$90.8K 0.01% 757
2022
Q2 		$26K Buy
2,000
+800
+67% +$12.2K 0.01% 792
2022
Q1 		$25K Sell
1,200
-100
-8% -$2K 0.04% 445
2021
Q4 		$31K Buy
+1,300
New +$31K 0.06% 464

Other funds holding STOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return

Aquatic Capital Management's STOK Position: Q3 2025 in Review

Aquatic Capital Management sold out of Stoke Therapeutics (STOK) in Q3 2025, closing a stake of 11,099 shares — an estimated $126K sold.

Aquatic Capital Management first reported a position in STOK in Q4 2021 and held it in 8 quarters. The position peaked at $157K in Q1 2025. 151 funds tracked by Wall St. Rank hold STOK as of Q3 2025.

  • Aquatic Capital Management reported no remaining Stoke Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 11,099 Stoke Therapeutics shares in Q3 2025, an estimated $126K.
  • Aquatic Capital Management first reported a position in Stoke Therapeutics in Q4 2021 and held it in 8 quarters.
  • Aquatic Capital Management's Stoke Therapeutics position peaked at $157K in Q1 2025.
  • 151 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.